Cheng Tuck Seng, Zahir Farzana, Carolin Solomi V, Verma Ashok, Rao Sereesha, Choudhury Saswati Sanyal, Deka Gitanjali, Mahanta Pranabika, Kakoty Swapna, Medhi Robin, Chhabra Shakuntala, Rani Anjali, Bora Amrit, Roy Indrani, Minz Bina, Bharti Omesh Kumar, Deka Rupanjali, Opondo Charles, Churchill David, Knight Marian, Kurinczuk Jennifer J, Nair Manisha
National Perinatal Epidemiology Unit, Nuffield Department of Population Health, Oxford University, Oxford, UK.
Department of Obstetrics and Gynaecology, Assam Medical College, Dibrugarh, Assam, India.
Lancet Reg Health Southeast Asia. 2024 May 7;25:100417. doi: 10.1016/j.lansea.2024.100417. eCollection 2024 Jun.
Guidelines for labour induction/augmentation involve evaluating maternal and fetal complications, and allowing informed decisions from pregnant women. This study aimed to comprehensively explore clinical and non-clinical factors influencing labour induction and augmentation in an Indian population.
A prospective cohort study included 9305 pregnant women from 13 hospitals across India. Self-reported maternal socio-demographic and lifestyle factors, and maternal medical and obstetric histories from medical records were obtained at recruitment (≥28 weeks of gestation), and women were followed up within 48 h after childbirth. Maternal and fetal clinical information were classified based on guidelines into four groups of clinical factors: (i) ≥2 indications, (ii) one indication, (iii) no indication and (iv) contraindication. Associations of clinical and non-clinical factors (socio-demographic, healthcare utilisation and lifestyle related) with labour induction and augmentation were investigated using multivariable logistic regression analyses.
Over two-fifths (n = 3936, 42.3%, 95% confidence interval [CI] 41.3-43.3%) of the study population experienced labour induction and more than a quarter (n = 2537, 27.3%, 95% CI 26.4-28.2%) experienced augmentation. Compared with women with ≥2 indications, those with one (adjusted odds ratio [aOR] 0.50, 95% CI 0.42-0.58) or no indication (aOR 0.24, 95% CI 0.20-0.28) or with contraindications (aOR 0.12, 95% CI 0.07-0.20) were less likely to be induced, adjusting for non-clinical characteristics. These associations were similar for labour augmentation. Notably, 34% of women who were induced or augmented did not have any clinical indication. Several maternal demographic (age at labour, parity and body mass index in early pregnancy), healthcare utilization (number of antenatal check-ups, duration of iron-folic acid supplementation and individuals managing childbirth) and socio-economic factors (religion, living below poverty line, maternal education and partner's occupation) were independently associated with labour induction and augmentation.
Although decisions about induction and augmentation of labour in our study population in India were largely guided by clinical recommendations, we cannot ignore that more than a third of the women did not have an indication. Decisions could also be influenced by non-clinical factors which need further research.
The MaatHRI platform is funded by a Medical Research Council Career Development Award (Grant Ref: MR/P022030/1) and a Transition Support Award (Grant Ref: MR/W029294/1).
引产/催产指南涉及评估母婴并发症,并让孕妇做出明智的决定。本研究旨在全面探索影响印度人群引产和催产的临床及非临床因素。
一项前瞻性队列研究纳入了印度13家医院的9305名孕妇。在招募时(妊娠≥28周)获取了自我报告的孕产妇社会人口统计学和生活方式因素,以及病历中的孕产妇医疗和产科病史,并在产后48小时内对这些女性进行随访。根据指南将母婴临床信息分为四组临床因素:(i)≥2项指征,(ii)一项指征,(iii)无指征,(iv)禁忌证。使用多变量逻辑回归分析研究临床和非临床因素(社会人口统计学、医疗保健利用和生活方式相关因素)与引产和催产之间的关联。
超过五分之二(n = 3936,42.3%,95%置信区间[CI] 41.3 - 43.3%)的研究人群经历了引产,超过四分之一(n = 2537,27.3%,95% CI 26.4 - 28.2%)经历了催产。与有≥2项指征的女性相比,有一项指征(调整后的优势比[aOR] 0.50,95% CI 0.42 - 0.58)、无指征(aOR 0.24,95% CI 0.20 - 0.28)或有禁忌证(aOR 0.12,95% CI 0.07 - 0.20)的女性引产的可能性较小,对非临床特征进行了调整。催产的情况也是如此。值得注意的是,34%接受引产或催产的女性没有任何临床指征。一些孕产妇人口统计学因素(分娩时年龄、产次和孕早期体重指数)、医疗保健利用因素(产前检查次数、铁叶酸补充剂服用时间和分娩管理人)以及社会经济因素(宗教、生活在贫困线以下、孕产妇教育程度和伴侣职业)与引产和催产独立相关。
尽管我们印度研究人群中关于引产和催产的决定在很大程度上是由临床建议指导的,但我们不能忽视超过三分之一的女性没有指征这一事实。这些决定也可能受到非临床因素的影响,这需要进一步研究。
MaatHRI平台由医学研究理事会职业发展奖(资助编号:MR/P022030/1)和过渡支持奖(资助编号:MR/W029294/1)资助。